China SXT Pharmaceuticals (SXTC) Shares Outstanding (Weighted Average): 2018-2025
- China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) rose 4863.74% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 4863.74%. This contributed to the annual value of $3.9 million for FY2025, which is 1308.87% up from last year.
- As of Q3 2025, China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $13.8 million, which was up 252.32% from $3.9 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $13.8 million during Q3 2025, and its lowest value of $3,879 during Q1 2021.
- Its 3-year average for Shares Outstanding (Weighted Average) is $3.1 million, with a median of $277,276 in 2024.
- Data for China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY surged of 4,863.74% (in 2025) over the last 5 years.
- China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarterly) stood at $3,881 in 2021, then skyrocketed by 161.71% to $10,157 in 2022, then surged by 462.87% to $57,171 in 2023, then skyrocketed by 384.99% to $277,276 in 2024, then skyrocketed by 4,863.74% to $13.8 million in 2025.
- Its Shares Outstanding (Weighted Average) was $13.8 million in Q3 2025, compared to $3.9 million in Q1 2025 and $277,276 in Q3 2024.
